The phrase "a viable end" is correct and usable in written English.
It can be used when discussing a feasible or practical conclusion or goal in various contexts, such as projects, plans, or discussions.
Example: "After evaluating all options, we concluded that pursuing a viable end is essential for the success of our initiative."
Alternatives: "a feasible outcome" or "a practical conclusion."
The usage of spent coffee grounds as non-structural fill material in embankments was found to be a viable end-of-life option to divert coffee grounds from landfills and furthermore to maximize the naturally high organic content present in the coffee grounds for vegetation purposes.
But a commercially viable, end-user-capable product probably won't be ready for at the very least several months.
In every case, mRNA expression was normalized by viable cell number at the end of the experiment and using GAPDH as loading control.
Or more fairly: do such "co-existence" projects actually change anything for the good?Seven years after the last serious peace talks collapsed, polls show that most Israelis and Palestinians still think a two-state solution is the only viable end to their conflict.
In April, the Jets signed Smith to a three-year contract, hoping to mold a 6-foot-6, 255-pound athlete into a viable tight end.
Indeed most of the materials used today are petro-based and cannot offer viable end of life treatment.
Another idea came from the University of Colorado Boulder, which has developed a prototype, which uses solar energy to transform both fecal material and urine into disinfected, commercially viable end products, the foundation said.
This paper, presenting a first-time comprehensive review of EBB, discusses the current advancements in EBB technology and highlights future directions to transform the technology to generate viable end products for tissue engineering and regenerative medicine.
To this end, this chapter presents near-future possibilities in bioprinting and provides the reader with promising directions for creating viable end products for use in tissue engineering, regenerative medicine, pharmacies, and clinics.
Alongside this, commercial developers require a full and comprehensive understanding of what policymakers (including publicly funded health services, such as the NHS) and patients value in pharmaceutical innovation in order to direct their innovation efforts towards commercially viable end points.
